Navitus Health Solutions Announces Key Leadership Changes For the Next Phase of Growth, Innovation

September 24, 2024

MADISON, WISCONSIN – September 24, 2024 – Navitus Health Solutions, announced today the appointment of Sharon Faust, PharmD, MBA, CSP, as its new Chief Pharmacy Officer (CPO). She succeeds Brent Eberle, RPh, who is departing to become President of CivicaScript. Also announced today is the appointment of Carrie Aiken as Chief Administrative Officer (CAO), and Darryl Munden as Chief Operating Officer (COO). Each of them will be expanding their current roles with these new responsibilities and all will report directly to Navitus Health Solutions CEO, David Fields. This furthers the company’s focus to grow as a pharmacy solutions provider, uniquely championing a transparent business model and a people-first mission.Sharon Faust joined Navitus in 2014, and was most recently the Senior Vice President of Specialty Pharmacy at Lumicera Health Services, a wholly-owned subsidiary of Navitus Health Solutions. Working alongside Eberle, they created a strong focus on keeping the patient at the center of every decision. Her leadership was pivotal to advancing accessibility of specialty products through Lumicera’s industry-leading cost-plus model and furthering a best-in-class patient support model. Lumicera delivers transparent, acquisition-cost pricing with no hidden fees along with condition-specific support from experienced clinicians and partners. The contributions of these leaders and their teams are exemplified by Lumicera achieving an exceptional patient net promoter score of 85.5.

“Lumicera is highly regarded for delivering superior pharmacy care. As Chief Pharmacy Officer for the broader organization, I will seek to champion these fundamentals and continue to put the needs of our clients and members first,” said Faust. “I am honored to have this opportunity to lead a world-class team and will continue to push for innovative, safe and effective ways to serve our clients, members, and patients every day.”

“Sharon’s extensive experience and proven track record with Lumicera make her the ideal leader to drive our mission of improving health outcomes and enhancing cost transparency,” said David Fields. “We recognize and thank Brent for his 20 years with our organization and the strides he’s made here. His leadership had a significant impact on our industry, including in the national discussions around PBM transparency and quality patient care. Navitus Health Solutions and CivicaScript share in our missions to make essential medications more accessible and affordable – we will continue to strengthen our efforts together with Brent at the helm.” 

Navitus doubles down on leadership and expertise to further solidify its position as a trusted innovator in the PBM landscape.

The Navitus PBM has maintained its unique model of passing all negotiated savings to plan sponsors and health plans. This approach allows Navitus to make medications more affordable for its clients and members, unlike traditional PBMs that retain an undisclosed portion of rebates, fees or network value for profit. With these new leadership appointments, Navitus seeks to further strengthen its market position, as the broader PBM industry faces increasing pressure for greater transparency, cost control, improved drug pricing and patient access.

These strategic roles are effective immediately:

  • Carrie Aiken is being promoted to Senior Vice President and Chief Administrative Officer. In addition to her duties as Chief Compliance Officer, Aiken will expand her responsibilities to oversee Human Resources.
  • Darryl Munden, currently Chief Enterprise Strategy and Technology Officer, will assume expanded responsibilities as Chief Operating Officer. Munden will have a concentrated focus on operational efficiencies, ensuring technology and business collaboration to streamline processes, optimize service and capabilities roadmaps, and enhance health outcomes for clients and members.

“These exceptional leaders reflect our commitment to developing talent and supporting growth from within our organization. We are confident we have the right team in place to effectively navigate the ever-evolving industry opportunities and challenges in order to drive future growth and impact,” added Fields.

About Navitus Health Solutions

Navitus Health Solutions is a pioneering pharmacy solutions provider that first launched a transparent pharmacy benefit manager (PBM) to pass through 100% of negotiated drug rebates and discounts to health plans and plan sponsors. The Navitus PBM is an alternative to traditional PBMs which divert rebates and discounts for profit. It leads the way in driving meaningful cost savings to help make medications more affordable. Now, more than 20 years later, the organization delivers a range of solutions through portfolio brands including NavitusEpiphanyRxLumicera, and Archimedes. Owned by SSM Health and Costco Wholesale, Navitus Health Solutions serves over 14 million lives across 800 clients including employers, unions, government plans, payors and health systems. For more information, please visit https://www.navitus.com/.

MORE ABOUT DAVID Fields

David Fields is the President and CEO at Navitus Health Solutions. He provides enterprise leadership and strategic direction for Navitus, collaborating with the executive management team to maintain Navitus strategic plan and to develop and direct its goals, policies and execution. David has held leadership positions on a number of boards, including the American Heart Association, American Red Cross, Labor-Management Council and the National Conference of Christians and Jews.

More About BRENT EBERLE

As Senior Vice President, Chief Pharmacy Officer, Brent oversees Navitus’ health strategies division, which is responsible for clinical and population health initiatives, drug utilization review programs, formulary and rebate management, and specialty pharmacy operations.

WRITTEN BY CARRIE AIKEN, CHC

Carrie serves as both the Vice President of Corporate Compliance and Navitus’ Compliance and Privacy Officer. She has more than 25 years of experience across multiple health care disciplines, including physician, hospital, home health and pharmacy, as well as contracting and revenue cycle management.

WRITTEN BY Sharon Faust, PharmD

Sharon, Chief Pharmacy Officer, oversees Health Strategies, Provider Services, and Lumicera Health Services, focusing on clinical initiatives, drug management, pharmacy networks, and procurement strategies across retail, mail, and specialty channels. Previously VP at Lumicera, a Navitus subsidiary, she advanced cost-plus specialty pharmacy models. With a clinical pharmacist background, Sharon holds a Doctor of Pharmacy and MBA, serves on industry boards, and was recognized as one of the top 50 leaders in pharmacy in 2023.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

The Role of Rebates in Pharmacy Benefits

The Role of Rebates in Pharmacy Benefits

In this blog, we’ll break down how rebates work, why they’ve come under increased scrutiny and how transparency — especially from your pharmacy benefit manager (PBM) — can help your organization truly lower prescription drug costs. …

PBM 101: Understanding Spread Pricing and Its Impact on Plan Costs 

PBM 101: Understanding Spread Pricing and Its Impact on Plan Costs 

There is no shortage of questions surrounding pharmacy benefit business models, especially when medication costs continue to rise. One major area of concern centers on a practice that often goes unnoticed or not understood: spread pricing.  …

Part D Star Ratings Adherence Measures: Enabling Strategic and Focused Support for High-risk Beneficiaries Through the Reporting and Intervention for Stars Excellence (RISE) Program

Part D Star Ratings Adherence Measures: Enabling Strategic and Focused Support for High-risk Beneficiaries Through the Reporting and Intervention for Stars Excellence (RISE) Program

Authors: Wenxuan Cai, PharmD, PhD; Amanda Lee, PharmD; Caitlin Albrecht, PharmD; Maria Basak, CPhT; Casey Herlache; Capriana Hadel, MBA Executive Summary Adherence to key medication classes is a critical metric for evaluating health plan quality and continuous…

PBM 101: How to Evaluate Your PBM

PBM 101: How to Evaluate Your PBM

Choosing a pharmacy benefit manager (PBM) isn’t just about managing prescription drug costs – it’s about ensuring your PBM operates in a way that aligns with your financial, operational and philosophical goals. A truly aligned PBM works toward the same…

Introducing NavitusClear with Costco® Cost Plus Model

Introducing NavitusClear with Costco® Cost Plus Model

NavitusClear is our designation awarded to partners that exemplify the level of transparency in drug pricing we believe should be the industry norm. This solution reflects the shared commitment between Navitus and Costco to address rising drug costs…

PBM 101: Understanding Transparency for Better Pharmacy Benefits

PBM 101: Understanding Transparency for Better Pharmacy Benefits

When it comes to pharmacy benefit managers (PBMs), the word “transparency” gets thrown around a lot. It’s frequently promised, widely discussed and inconsistently delivered.  …

Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

In this overview of our national Legal Ease webinar event, we highlight key federal and state developments shaping the conversation around PBM reform – and what they mean for your clients.  …

Navigating the Drug Supply Chain: What You Need to Know

Navigating the Drug Supply Chain: What You Need to Know

Before a prescription ever reaches a pharmacy counter, it has already moved through a complex ecosystem known as the drug supply chain. From manufacturers and wholesalers to pharmacy benefit managers (PBMs) and pharmacies, each entity plays a role in…

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

previous arrow
next arrow